MRVI | Maravai LifeSciences Holdings, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	5.08 - 5.35
52 Week Range	4.28 - 11.56
Beta	-0.07
Implied Volatility	103.59%
IV Rank	76.02%
Day's Volume	685,160
Average Volume	1,782,579
Shares Outstanding	141,844,000
Market Cap	756,028,520
Sector	Healthcare
Industry	Biotechnology
IPO Date	2020-11-20

Valuation
Profitability
Growth
Health
P/E Ratio	-3.19
Forward P/E Ratio	42.73
EPS	-1.67
1YR Price Target	20.50
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	580
Country	USA
Website	MRVI

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It generates a majority of its revenue from the Nucleic Acid Production that focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

MRVI's peers: ROIV, KRYS, RXDX, AKRO, APLS, HALO, AGIO, INSM, CERE, RARE, ALEC, LEGN, ASND, CYTK, EWTX, FOLD, INCY, DNLI, ARGX, HRMY, ABUS, IMVT, ARQT, PTGX

*Chart delayed

Analyzing fundamentals for MRVI we got that it has average fundamentals where Valuation is considered to be slightly undervalued, Profitability is unacceptably poor, Growth is very good and Health is passable. For more detailed analysis please see MRVI Fundamentals page.

Watching at MRVI technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on MRVI Technicals page.